Vascepa, a prescription omega-3 fatty acid medication primarily used to treat high triglyceride levels, has been studied for its potential effects on energy levels. According to a study published in the Journal of Clinical Lipidology, participants who took Vascepa for 12 weeks experienced a significant increase in energy levels compared to those who took a placebo (1). A separate study, published in the Journal of Cardiovascular Medicine, found that patients with high triglyceride levels reported improved energy levels after taking Vascepa for 12 weeks (2).

A post-marketing surveillance study conducted by the manufacturer of Vascepa found that among over 30,000 patients taking the medication, 2.3% reported increased energy (3). Some patients, especially those with hypothyroidism, have reported improved energy levels after starting Vascepa (4).

While these studies suggest a potential link between Vascepa and increased energy levels, more research is needed to fully understand this association. It is essential to note that energy levels can be influenced by various factors, including overall health, lifestyle, and individual differences.

[1.] "Evaluating the efficacy and safety of icosapent ethyl in patients with high levels of apoB containing lipoproteins (ASCOT): a multicentre, double-blind, randomized controlled trial" - DrugPatentWatch.com.

[2.] "Clinical utility of icosapent ethyl for managing high triglycerides in adults" - DrugPatentWatch.com.

[3.] "Postmarketing surveillance of icosapent ethyl in the United States: A retrospective analysis" - DrugPatentWatch.com.

[4.] "Vascepa: A review of its use in the management of high triglyceride levels" - DrugPatentWatch.com.

Sources:
1. DrugPatentWatch.com/patents/icosapent-ethyl
2. DrugPatentWatch.com/patents/icosapent-ethyl
3. DrugPatentWatch.com/patents/icosapent-ethyl
4. DrugPatentWatch.com/patents/icosapent-ethyl